ACT 1613/2025

—·EP3175863: VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

Case details: Status
—
Action
Infringement
Category
Main Infringement Action
Parties: Claimants
BioMarin Pharmaceutical Inc.
Reps: Christian Paul (Jones Day); Tobias Mandler (Jones Day); Pascal Grandé (Jones Day)
Respondents
Ascendis Pharma A/S
Ascendis Pharma Growth Disorders A/S
Reps: Agathe Michel-De Cazotte (Carpmaels & Ransford); Anna Leathley (Carpmaels & Ransford); Daniel Wiese (Carpmaels & Ransford)
Division: Munich LD
Judges: Matthias Zigann · Presiding Judge / Judge-Rapporteur
Andras Kupecz · Legally Qualified Judge
Tobias Pichlmaier · Legally Qualified Judge
Technology: Biotech · Peptide Therapeutics · Biotechnology
Language: —
First decided: Jun 2, 2025

Decisions

2025-06-02
Infringement Action
Scheduling order by Munich Local Division (UPC_CFI_18/2025 and UPC_CFI_439/2025, 2 June 2025) setting dates for interim conference (9 January 2026, videoconference) and oral hearing (18 March 2026, Munich) in BioMarin's infringement action against Ascendis Pharma, with counterclaim for revocation. Both proceedings will proceed together; a technically qualified judge will be appointed.
Legal issues:Case management / scheduling (R. 28, 33, 37.2 RoP)Consolidation of infringement action and revocation counterclaim

Documents